Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
MINISO
MNSO
$3.08B
| $4.45M | ﹤0.01% |
292,088
+185,163
| +173% | +$2.83M |
|
2952
Devon Energy
DVN
$52.1B
| $4.45M | ﹤0.01% |
125,330
-852,009
| -87% | -$24.2M |
|
|
CNBKA
2953
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $4.45M | ﹤0.01% |
38,599
+10,761
| +39% | +$1.23M |
|
|
ISLE
2954
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
| $4.44M | ﹤0.01% |
452,084
+53,611
| +13% | +$523K |
|
|
SCLEU
2955
DELISTED
Broadscale Acquisition Corp. Units
SCLEU
| $4.44M | ﹤0.01% |
449,103
-546,597
| -55% | -$5.43M |
|
|
PPL
2956
PPL Corp
PPL
$25.7B
| $4.44M | ﹤0.01% |
159,110
-2,597,605
| -94% | -$74.9M |
|
2957
Interparfums
IPAR
$3.77B
| $4.43M | ﹤0.01% |
59,285
-12,320
| -17% | -$901K |
|
|
MPT
2958
PUT
Medical Properties Trust
MPT
$2.44B
| $4.43M | ﹤0.01% |
+220,900
| New | +$4.53M |
|
2959
PUT
IQVIA
IQV
$43.1B
| $4.43M | ﹤0.01% |
18,500
-16,100
| -47% | -$4.06M |
|
2960
WD-40
WDFC
$2.91B
| $4.43M | ﹤0.01% |
19,134
+2,208
| +13% | +$530K |
|
|
FLAC
2961
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
| $4.43M | ﹤0.01% |
450,862
+218,000
| +94% | +$2.13M |
|
2962
CALL
Constellation Brands
STZ
$22.3B
| $4.42M | ﹤0.01% |
21,000
-187,200
| -90% | -$40.9M |
|
|
LDHAU
2963
DELISTED
LDH Growth Corp I Units
LDHAU
| $4.42M | ﹤0.01% |
448,917
-27,606
| -6% | -$274K |
|
|
AOMR
2964
Angel Oak Mortgage REIT
AOMR
$194M
| $4.42M | ﹤0.01% |
261,120
+73,940
| +40% | +$1.31M |
|
|
PDCO
2965
DELISTED
Patterson Companies, Inc.
PDCO
| $4.42M | ﹤0.01% |
146,696
-673,332
| -82% | -$20.4M |
|
|
SCOB
2966
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $4.42M | ﹤0.01% |
453,444
+150,443
| +50% | +$1.46M |
|
2967
CDW
CDW
$18.5B
| $4.42M | ﹤0.01% |
+24,269
| New | +$4.58M |
|
2968
CALL
Apollo Global Management
APO
$79.7B
| $4.42M | ﹤0.01% |
+71,700
| New | +$4.31M |
|
2969
Clover Health Investments
CLOV
$2.25B
| $4.42M | ﹤0.01% |
597,589
-410,142
| -41% | -$3.51M |
|
|
HTO
2970
H2O America
HTO
$2.66B
| $4.41M | ﹤0.01% |
66,820
-27,617
| -29% | -$1.86M |
|
2971
Inspire Medical Systems
INSP
$1.78B
| $4.41M | ﹤0.01% |
18,945
-140,599
| -88% | -$29.3M |
|
2972
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $4.41M | ﹤0.01% |
60,034
-3,246
| -5% | -$247K |
|
|
NXGN
2973
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.41M | ﹤0.01% |
312,903
-60,570
| -16% | -$942K |
|
|
POND
2974
DELISTED
Angel Pond Holdings Corporation
POND
| $4.41M | ﹤0.01% |
+456,558
| New | +$4.4M |
|
2975
Arbutus Biopharma
ABUS
$1B
| $4.38M | ﹤0.01% |
+1,021,695
| New | +$3.4M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.